Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Immunomedics Inc

+ Add to Watchlist

IMMU:US

4.1000 USD 0.0200 0.49%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Immunomedics Inc (IMMU)

Open: 4.0500 Day's Range: 3.9800 - 4.1200 Volume: 848,740
Previous Close: 4.0800 52wk Range: 3.0800 - 5.4800 1-Yr Rtn: +22.75%

Stock Chart for IMMU

No chart data available.
  • IMMU:US 4.1000
  • 1D
  • 1M
  • 1Y
4.0800
Interactive IMMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMMU

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5100
Est. EPS (USD) (06/2015) -0.5070
Est. PEG Ratio -
Market Cap (M USD) 383.20
Shares Outstanding (M) 93.46
30 Day Average Volume 935,827
Price/Book (mrq) 71.6655
Price/Sale (ttm) 84.9339
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0010
Dividend Ex-Date 03/15/2002
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMMU

Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

David M GoldenbergChairman/FounderCynthia L SullivanPresident/CEO
Francois E WilhelmChief Medical OfficerPeter P PfreundschuhVP:Finance/CFO
More Company Profile & Key Executives for IMMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil